Socially Responsible Property Investment in Cities – Between Economic Reasoning and Social Obligations

by Brodowicz Dominika P.
Published 2017-06-01

Case Report of Suspected Rhabdomyolysis during Treatment with Trabectedin in a Patient with Metastatic Leiomyosarcoma

by Lamm, W., Amann, G., Brodowicz, T.
Published 2010

Bone matters in lung cancer

by Brodowicz, T., O'Byrne, K., Manegold, C.
Published 2012

Pazopanib in Primary Cardiac Angiosarcoma of the Right Atrium: A Case Report

by Schur, Sophie, Hamacher, Rainer, Brodowicz, Thomas
Published 2016

P02.92. The effect of physical activity, obesity, and low vitamin D on all cause mortality in US adults

by Crespo, C, Escutia-Dominguez, G, Smit, E, Brodowicz, G, Aden, S
Published 2012

Sarcoma of the Ewing Family in Pregnancy: A Case Report of Intrauterine Fetal Death after Induction of Chemotherapy

by Schur, S., Wild, J., Amann, G., Köstler, W., Langer, M., Brodowicz, T.
Published 2012

Bone metastases: Are we failing our patients?

by Tombal, B., Diel, I., Drudge-Coates, L., Haynes, I., Brodowicz, T.
Published 2014

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.

by Zielinski, C. C., Schnack, B., Grbovic, M., Brodowicz, T., Wiltschke, C., Steger, G., Pflüger, H., Marberger, M.
Published 1998

Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer.

by Hejna, M., Kornek, G. V., Raderer, M., Depisch, D., Brodowicz, T., Fiebiger, W. C., Scheithauer, W.
Published 1998

Children immunization – knowledge and attitudes of parents

by Trojanowska Alina, Zarzycka Danuta, Brodowicz-Król Magdalena, Jędrzejewski Arkadiusz, Wiktor Anna
Published 2016-12-01

Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer-...

by Loibl, Sibylle, Skacel, Tomas, Nekljudova, Valentina, Lück, Hans Joachim, Schwenkglenks, Matthias, Brodowicz, Thomas, Zielinski, Christoph, von Minckwitz, Gunter
Published 2011

Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)†

by Obasaju, C., Bowman, L., Wang, P., Shen, W., Winfree, K. B., Smyth, E. N., Boye, M. E., John, W., Brodowicz, T., Belani, C. P.
Published 2013

The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma

by Schwameis, Richard, Grimm, Christoph, Petru, Edgar, Natter, Camilla, Staudigl, Christine, Lamm, Wolfgang, Koelbl, Heinz, Krainer, Michael, Brodowicz, Thomas, Reinthaller, Alexander, Polterauer, Stephan
Published 2015

Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma

by Schwameis, Richard, Grimm, Christoph, Brodowicz, Thomas, Petru, Edgar, Hefler-Frischmuth, Katrin, Staudigl, Christine, Reinthaller, Alexander, Heinze, Georg, Polterauer, Stephan, Polterauer, Mariella
Published 2016

Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

by Zielinski, Christoph, Lang, Istvan, Beslija, Semir, Kahan, Zsuzsanna, Inbar, Moshe J, Stemmer, Salomon M, Anghel, Rodica, Vrbanec, Damir, Messinger, Diethelm, Brodowicz, Thomas
Published 2016

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: results...

by Thallinger, Christiane, Lang, Istvan, Kuhar, Cvetka Grasic, Bartsch, Rupert, Singer, Christian F., Petruzelka, Lubos, Melichar, Bohuslav, Knittelfelder, Regina, Brodowicz, Thomas, Zielinski, Christoph
Published 2016

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

by Prager, Gerald W, Braemswig, Kira H, Martel, Alexandra, Unseld, Matthias, Heinze, Georg, Brodowicz, Thomas, Scheithauer, Werner, Kornek, Gabriela, Zielinski, Christoph C
Published 2014

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma

by Lamm, Wolfgang, Natter, Camilla, Schur, Sophie, Köstler, Wolfgang J, Reinthaller, Alexander, Krainer, Michael, Grimm, Christoph, Horvath, Reinhard, Amann, Gabriele, Funovics, Philipp, Brodowicz, Thomas, Polterauer, Stephan
Published 2014

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

by Brodowicz, Thomas, Liegl-Atzwager, Bernadette, Tresch, Emmanuelle, Taieb, Sophie, Kramar, Andrew, Gruenwald, Viktor, Vanseymortier, Marie, Clisant, Stéphanie, Blay, Jean-Yves, Le Cesne, Axel, Penel, Nicolas
Published 2015

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

by Brodowicz, T, Lang, I, Kahan, Z, Greil, R, Beslija, S, Stemmer, S M, Kaufman, B, Petruzelka, L, Eniu, A, Anghel, R, Koynov, K, Vrbanec, D, Pienkowski, T, Melichar, B, Spanik, S, Ahlers, S, Messinger, D, Inbar, M J, Zielinski, C
Published 2014